Alamar Biosciences, Inc.
ALMR
$20.74
$0.542.67%
NASDAQ
| 03/31/2026 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 26.04M | 13.09M | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 26.04M | 13.09M | |||
| Cost of Revenue | 11.58M | 6.70M | |||
| Gross Profit | 14.46M | 6.39M | |||
| SG&A Expenses | 13.79M | 6.64M | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 38.38M | 21.64M | |||
| Operating Income | -12.35M | -8.55M | |||
| Income Before Tax | -20.86M | -7.66M | |||
| Income Tax Expenses | 464.00K | -- | |||
| Earnings from Continuing Operations | -21.33M | -7.66M | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -21.33M | -7.66M | |||
| EBIT | -12.35M | -8.55M | |||
| EBITDA | -11.18M | -7.67M | |||
| EPS Basic | -1.74 | -0.68 | |||
| Normalized Basic EPS | -0.63 | -0.43 | |||
| EPS Diluted | -1.74 | -0.68 | |||
| Normalized Diluted EPS | -0.63 | -0.43 | |||
| Average Basic Shares Outstanding | 12.26M | 11.26M | |||
| Average Diluted Shares Outstanding | 12.26M | 11.26M | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||